-
公开(公告)号:EP1848435B1
公开(公告)日:2016-01-20
申请号:EP06719652.7
申请日:2006-01-25
发明人: SUN, Lijun , CHEN, Shoujun , JIANG, Jun , YU, Chih-yi , XIE, Yu
IPC分类号: A61K31/4965 , C07D401/00 , C07D403/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00 , C07D239/02 , A61K31/505 , A61K31/50 , A61K31/497 , A61P37/00 , A61P29/00 , C07D401/14 , C07D405/14 , C07D413/14 , A61K31/495 , C07D401/12 , C07D403/10
CPC分类号: C07D241/20 , A61K31/495 , A61K31/4965 , A61K31/497 , A61K31/50 , A61K31/505 , C07D401/12 , C07D401/14 , C07D403/10 , C07D405/14 , C07D413/10 , C07D413/14 , C07D417/14 , Y02A50/422
摘要: The invention relates to compounds of structural formula (I) and structural formula (VI): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein R, R1, R2, Z, L, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
-
2.Aminoheteroaryl compounds as protein kinase inhibitors 有权
标题翻译: 氨基杂芳基 - Verbindungen als Proteinkinase-Hemmer公开(公告)号:EP2476667A2
公开(公告)日:2012-07-18
申请号:EP12163855.5
申请日:2004-02-26
申请人: Sugen, Inc.
发明人: Cui, Jingjong, Jean , Johnson, Joanne , Kolodziej, Stephen, A. , Kung, Pei-Pei , Li, Xiaoyuan (Sharon) , Lin, Jason (Qishen) , Meng, Jerry Jialun , Nambu, Mitchell David , Nelson, Christopher G. , Pairish, Mason Alan , Shen, Hong , Zhang, Jennifer , Tran-Dube, Michelle , Walter, Allison , Zhang, Fang-Jie , Hanau, Cathleen Elizabeth , Bhumralkar, Dilip , Botrous, Iriny , Chu, Ji Yu , Funk, Lee A. , Harris Jr., G. Davis , Jia, Lei
IPC分类号: C07D213/73 , A61K31/4965 , C07D401/00 , C07D403/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00 , C07D211/72 , A61P35/00
CPC分类号: C07D213/73 , A61K45/06 , C07D401/12 , C07D413/12
摘要: Aminopyridine and aminopyrazine compounds of formula (1), compositions including these compounds, and methods of their use are provided. Preferred compounds of formula 1 have activity as protein kinase inhibitors, including as inhibitors of c-MET.
摘要翻译: 提供式(1)的氨基吡啶和氨基吡嗪化合物,包括这些化合物的组合物及其使用方法。 优选的式1化合物具有作为蛋白激酶抑制剂的活性,包括作为c-MET的抑制剂。
-
公开(公告)号:EP1603570A2
公开(公告)日:2005-12-14
申请号:EP04715001.6
申请日:2004-02-26
申请人: Sugen, Inc.
发明人: CUI, Jingjong, Jean , ZHANG, Jennifer , HANAU, Cathleen Elizabeth , BHUMRALKAR, Dilip , BOTROUS, Iriny , CHU, Ji Yu , FUNK, Lee A. , HARRIS Jr., G. Davis , JIA, Lei , JOHNSON, Joanne , KOLODZIEJ, Stephen A. , KUNG, Pei-Pei , LI, Xiaoyuan (Sharon) , LIN, Jason (Qishen) , MENG, Jerry Jialun , NAMBU, Mitchell David , NELSON, Christopher G. , PAIRISH, Mason Alan , SHEN, Hong , TRAN-DUBE, Michelle , WALTER, Allison , ZHANG, Fang-Jie
IPC分类号: A61K31/4965 , C07D401/00 , C07D403/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00 , C07D211/72
CPC分类号: C07D213/73 , A61K45/06 , C07D401/12 , C07D413/12
摘要: Aminopyridine and aminopyrazine compounds of formula (1), compositions including these compounds, and methods of their use are provided. Preferred compounds of formula 1 have activity as protein kinase inhibitors, including as inhibitors of c-MET.
-
4.
公开(公告)号:EP1066279A4
公开(公告)日:2004-09-08
申请号:EP99909753
申请日:1999-03-03
发明人: POINDEXTER GRAHAM S , ANTAL ILDIKO , GIUPPONI LEAH M , STOFFEL ROBERT H , GILLMAN KEVIN , HIGGINS MENDI
IPC分类号: A61K31/4164 , A61K31/4166 , A61K31/4178 , A61K31/4192 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/497 , A61K31/506 , A61K31/5377 , A61K31/541 , A61P3/04 , A61P43/00 , C07D233/70 , C07D233/72 , C07D233/74 , C07D233/76 , C07D233/78 , C07D233/84 , C07D233/86 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/10 , C07D403/12 , C07D405/04 , C07D405/06 , C07D405/10 , C07D405/12 , C07D409/06 , C07D409/12 , C07D413/10 , C07D403/00 , A61K31/415 , A61K31/44 , A61K31/495 , C07D233/30 , C07D233/32 , C07D403/02 , C07D411/00
CPC分类号: A61K31/4174 , A61K31/4166 , A61K31/4178 , C07D233/70 , C07D233/74 , C07D233/76 , C07D233/78 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D409/06
-
5.IMIDAZOLONE ANORECTIC AGENTS: III. HETEROARYL DERIVATIVES 审中-公开
标题翻译: ANOREKTISCHE IMIDAZOLONVERBINDUNGEN:III。 HETEROARYLVERBINDUNGEN公开(公告)号:EP1066278A4
公开(公告)日:2004-09-01
申请号:EP99909752
申请日:1999-03-03
发明人: POINDEXTER GRAHAM S , GILLMAN KEVIN
IPC分类号: A61K31/4164 , A61K31/4166 , A61K31/4178 , A61K31/4192 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/497 , A61K31/506 , A61K31/5377 , A61K31/541 , A61P3/04 , A61P43/00 , C07D233/70 , C07D233/72 , C07D233/74 , C07D233/76 , C07D233/78 , C07D233/84 , C07D233/86 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/10 , C07D403/12 , C07D405/04 , C07D405/06 , C07D405/10 , C07D405/12 , C07D409/06 , C07D409/12 , C07D413/10 , C07D403/00 , A61K31/415 , A61K31/44 , A61K31/495 , C07D233/30 , C07D233/32 , C07D403/02 , C07D411/00
CPC分类号: A61K31/4174 , A61K31/4166 , A61K31/4178 , C07D233/70 , C07D233/74 , C07D233/76 , C07D233/78 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D409/06
-
6.METHOD OF SYNTHESIZING BARBITURIC ACID DERIVATIVES AND THEIR USE FOR THE SYNTHESIS OF CHEMICAL LIBRARIES 审中-公开
标题翻译: PRODUCING巴比妥衍生物的方法,以及它们在化学库生产公开(公告)号:EP1155002A4
公开(公告)日:2003-03-19
申请号:EP00910081
申请日:2000-02-04
申请人: TRANSTECH PHARMA INC
发明人: MJALLI ADNAN M M
IPC分类号: C07D239/62 , C07B61/00 , C07D239/60 , C07F7/08 , C07D239/02 , C07D401/00 , C07D403/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00
CPC分类号: C07D239/60 , C40B40/00
摘要: A support template of Formula (1).
-
7.4-UNSUBSTITUTED DIHYDROISOQUINOLINONE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF 审中-公开
标题翻译: 4-取代二氢异喹啉酮衍生物及其组合文库公开(公告)号:EP1210598A1
公开(公告)日:2002-06-05
申请号:EP00955287.8
申请日:2000-07-28
申请人: LION bioscience AG
IPC分类号: G01N33/53 , G01N33/543 , G01N33/566 , C07D217/00 , C07D217/02 , C07D217/06 , C07D217/22 , C07D311/04 , C07D311/74 , C07D311/76 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00
CPC分类号: C07D401/04 , C07D217/24 , C07D405/12 , C40B40/00 , G01N2333/665 , G01N2333/70 , G01N2333/726 , G01N2500/00
摘要: The present invention relates to novel dihydroisoquinolinone (DHQ) derivative compounds of formula (I): wherein R1 to R7, X, Y, Z, b, c and d have the meanings provided herein. The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing DHQ derivative compounds.
摘要翻译: 本发明涉及式(I)的新型二氢异喹啉酮(DHQ)衍生物化合物:其中R 1至R 7,X,Y,Z,b,c和d具有本文提供的含义。 本发明进一步涉及含有两种或更多种此类化合物的组合文库,以及制备DHQ衍生物化合物的方法。
-
公开(公告)号:EP0157963A1
公开(公告)日:1985-10-16
申请号:EP84302097.5
申请日:1984-03-28
IPC分类号: C07D327/02 , C07D411/00 , C07D417/04 , A61K31/41 , A61K31/39
CPC分类号: C07D411/04 , C07D327/02 , C07D411/06 , C07D417/04 , C07D417/12
摘要: Novel 6H-dibenz [b, e] [1, 4] oxathiepin derivatives of the formulae I and la are employed in the treatment and control of allergic conditions such as allergic asthma.
摘要翻译: 式I和Ia的新型6H-二苯并[b,e] [1,4]氧硫杂环庚烯衍生物用于治疗和控制过敏性病症如过敏性哮喘。
-
公开(公告)号:EP1603570B9
公开(公告)日:2013-10-23
申请号:EP04715001.6
申请日:2004-02-26
申请人: Sugen, Inc.
发明人: CUI, Jingjong, Jean , ZHANG, Jennifer , HANAU, Cathleen Elizabeth , BHUMRALKAR, Dilip , BOTROUS, Iriny , CHU, Ji Yu , FUNK, Lee A. , HARRIS Jr., G. Davis , JIA, Lei , JOHNSON, Joanne , KOLODZIEJ, Stephen A. , KUNG, Pei-Pei , LI, Xiaoyuan (Sharon) , LIN, Jason (Qishen) , MENG, Jerry Jialun , NAMBU, Mitchell David , NELSON, Christopher G. , PAIRISH, Mason Alan , SHEN, Hong , TRAN-DUBE, Michelle , WALTER, Allison , ZHANG, Fang-Jie
IPC分类号: A61K45/06 , C07D213/73 , A61K31/4965 , C07D401/00 , C07D403/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00 , C07D211/72 , A61P35/00
CPC分类号: C07D213/73 , A61K45/06 , C07D401/12 , C07D413/12
-
10.
公开(公告)号:EP1027056B1
公开(公告)日:2009-02-25
申请号:EP98953274.2
申请日:1998-10-07
申请人: CEPHALON, INC.
IPC分类号: A61K31/55 , A61K31/495 , A61K31/50 , A61K31/40 , C07D401/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D415/00 , C07D209/48 , C07D403/12
CPC分类号: C07D209/48 , C07D403/12
摘要: This invention relates to α-ketoamide inhibitors of multicatalytic protease (MCP), to compositions including such inhibitors, and to methods for the use of MCP inhibitors. The MCP inhibitors of the present invention are useful, for example, to retard loss of muscle mass incident to various physiological states.
-
-
-
-
-
-
-
-
-